Results 251 to 260 of about 5,297,540 (313)
Elastography and MRI for the Evaluation of Complete Response to Neoadjuvant Therapy for Breast Cancer. [PDF]
Horvat JV, Fazzio RT.
europepmc +1 more source
ABSTRACT The present study compared the short‐term outcomes and perioperative complications of robotic‐assisted colectomy (RAC) and laparoscopic‐assisted colectomy (LAC) in patients with colon cancer. This retrospective study included patients with histologically confirmed colon adenocarcinoma who underwent either RAC or LAC at five medical centers in ...
Ching‐Wen Huang +5 more
wiley +1 more source
Quality of life following total neoadjuvant therapy for rectal cancer. [PDF]
Wurschi GW +15 more
europepmc +1 more source
Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik +3 more
wiley +1 more source
Factors Driving Attrition from Neoadjuvant Therapy to Pancreatectomy in Localized Pancreatic Cancer. [PDF]
Dickey EM +10 more
europepmc +1 more source
ABSTRACT Gastric cancer (GC) is the fifth most common type worldwide, representing a public health problem. Among the genes related to this tumorigenesis, the family of matrix metalloproteinases (MMPs), essential regulators of the extracellular matrix (ECM), stand out for their involvement in the development and progression of GC.
Aline Costa Bastos +11 more
wiley +1 more source
Editorial: The role of adjuvant and neoadjuvant therapy in resectable esophageal cancer. [PDF]
Li X, Cong Z, Qiang Y.
europepmc +1 more source
ABSTRACT Prostate cancer (PCa) is the second most frequently diagnosed malignancy among men and the sixth leading cause of cancer‐related mortality worldwide. Radical prostatectomy remains the standard treatment for localized disease; however, approximately one‐third of patients develop biochemical recurrence within 10 years. Although prostate‐specific
Juliana Ramos Chaves +7 more
wiley +1 more source
Neoadjuvant Radiochemotherapy and Total Neoadjuvant Therapy in the Management of Locally Advanced Rectal Cancer. [PDF]
Yigit M +6 more
europepmc +1 more source
The combination of immune checkpoint inhibitors (ICIs) and radiotherapy synergistically enhances efficacy through an “antigen release‐immune activation” closed‐loop mechanism, significantly improving outcomes in solid tumors (e.g., lung cancer, melanoma).
Guiling Song +5 more
wiley +1 more source

